Our Generic Drug Supply Is Sick
Competition for market share at rock-bottom prices has led to shortages, price-spikes, allegations of price-fixing, and substandard and even dangerous practices.
Competition for market share at rock-bottom prices has led to shortages, price-spikes, allegations of price-fixing, and substandard and even dangerous practices.
The study found that the shots’ effectiveness in preventing hospitalization fell to 77 percent from 91 percent four months after full vaccination.
Too often, seniors who use opioids become targets for exploitation and abuse.
A professor, a psychiatrist and a nurse react to a Times investigation. Also: A modern Civil War; a more confident child.
Senior Democrats said they could still preserve elements of their plan to lower prescription drug prices, but they have little room for defections, and divisions remain on that and other issues.
An attempt in the House to take a bite out of drug companies meets resistance.
Independent experts, including government scientists, were skeptical of the research from Israel, which included limited data over a short period.
In both the House and the Senate, Democrats are working to resolve their internal differences on a huge social policy measure that will require near-total unity to pass.
Progressive senators pushed back hard on the decision by senior Democrats to focus a $2.1 trillion package of tax increases on income, not wealth.
Such treatments are extraordinarily promising and costly. Will the Biden administration commit to spending that could speed clinical trial results?